BioCorteX
Digital medicine company applying artificial intelligence and computational biology to precision oncology, developing data-driven approaches to identify novel drug targets and treatment strategies for cancer.
Website
https://www.biocortex.comLocation
Munich, Germany
Founded
2018
Investors
1
Categories
digital-medicine, ai, precision-oncology, computational-biology, drug-discovery
Notes
BioCorteX is a digital medicine company that combines artificial intelligence with computational biology to advance precision oncology. The company's platform analyzes complex biological data to identify novel drug targets, predict treatment responses, and develop more effective cancer therapies.
By integrating multi-omics data with clinical information, BioCorteX aims to accelerate drug discovery and enable more personalized treatment approaches for cancer patients.
Team
- Leadership team information available on company website
Additional Research Findings
- Portfolio company of Sofinnova Partners
- Part of Sofinnova Digital Medicine Strategy
- Focus on AI-driven precision oncology
- Computational approaches to drug discovery
- Multi-omics data analysis platform
- Munich-based with European operations
- Targeting novel cancer drug targets and biomarkers
Sources
- BioCorteX Official Website
- Sofinnova Partners Portfolio
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |